<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>AREVA North America: Next Energy Blog &#187; Nuclear Medicine</title>
	<atom:link href="http://us.arevablog.com/category/nuclear-energy/nuclear-medicine/feed/" rel="self" type="application/rss+xml" />
	<link>http://us.arevablog.com</link>
	<description>Next Energy Blog</description>
	<lastBuildDate>Thu, 29 Jul 2010 19:09:43 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.1</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>AREVA Med: New Research Agreement with University of Cincinnati</title>
		<link>http://us.arevablog.com/2010/04/13/areva-med-new-research-agreement-with-university-of-cincinnati/</link>
		<comments>http://us.arevablog.com/2010/04/13/areva-med-new-research-agreement-with-university-of-cincinnati/#comments</comments>
		<pubDate>Tue, 13 Apr 2010 21:19:16 +0000</pubDate>
		<dc:creator>AREVA North America Blog</dc:creator>
				<category><![CDATA[AREVA News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Nuclear Energy]]></category>
		<category><![CDATA[Nuclear Medicine]]></category>

		<guid isPermaLink="false">http://us.arevablog.com/?p=2597</guid>
		<description><![CDATA[AREVA subsidiary AREVA Med and the University of Cincinnati, Ohio, announced today that they have signed a research agreement to develop a new treatment to combat cancer.  Under the agreement, AREVA will provide the medical-grade isotope Lead-212 to the university for researchers to conduct studies on alpha radio-immunotherapy which uses this isotope to treat [...]]]></description>
		<wfw:commentRss>http://us.arevablog.com/2010/04/13/areva-med-new-research-agreement-with-university-of-cincinnati/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AREVA to Build Facility for Medical Isotope Production</title>
		<link>http://us.arevablog.com/2010/03/10/areva-to-build-facility-for-medical-isotope-production/</link>
		<comments>http://us.arevablog.com/2010/03/10/areva-to-build-facility-for-medical-isotope-production/#comments</comments>
		<pubDate>Wed, 10 Mar 2010 22:04:54 +0000</pubDate>
		<dc:creator>AREVA North America Blog</dc:creator>
				<category><![CDATA[AREVA News]]></category>
		<category><![CDATA[News]]></category>
		<category><![CDATA[Nuclear Energy]]></category>
		<category><![CDATA[Nuclear Medicine]]></category>

		<guid isPermaLink="false">http://us.arevablog.com/?p=2422</guid>
		<description><![CDATA[AREVA Med, an AREVA subsidiary, announced today the future construction of a facility in France that will produce on a large-scale medical grade lead 212.
Why Lead-212?
Lead-212 is a rare radioactive isotope that lies at the heart of promising nuclear medical research to develop new cancer treatments.  Over the past few years, AREVA Med and [...]]]></description>
		<wfw:commentRss>http://us.arevablog.com/2010/03/10/areva-to-build-facility-for-medical-isotope-production/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>A Look at AREVA’s Work for the Advancement of Nuclear Medicine</title>
		<link>http://us.arevablog.com/2009/11/10/a-look-at-areva%e2%80%99s-work-for-the-advancement-of-nuclear-medicine/</link>
		<comments>http://us.arevablog.com/2009/11/10/a-look-at-areva%e2%80%99s-work-for-the-advancement-of-nuclear-medicine/#comments</comments>
		<pubDate>Tue, 10 Nov 2009 17:30:23 +0000</pubDate>
		<dc:creator>AREVA North America Blog</dc:creator>
				<category><![CDATA[Nuclear Energy]]></category>
		<category><![CDATA[Nuclear Medicine]]></category>
		<category><![CDATA[Alpha-RIT]]></category>
		<category><![CDATA[AREVA Inc.]]></category>
		<category><![CDATA[AREVA Med]]></category>
		<category><![CDATA[AREVA North America]]></category>
		<category><![CDATA[France]]></category>
		<category><![CDATA[La Hague]]></category>
		<category><![CDATA[Nuclear Power]]></category>
		<category><![CDATA[TF1]]></category>

		<guid isPermaLink="false">http://us.arevablog.com/?p=1246</guid>
		<description><![CDATA[by Katherine Berezowskyj
Last week France’s TF1 television network featured AREVA’s innovative work under way in partnership with the U.S. National Cancer Institute and the University of Alabama for the development of a treatment to fight cancer.
The news team got to take a look inside AREVA’s La Hague Facility, in Normandy, where the idea of using [...]]]></description>
		<wfw:commentRss>http://us.arevablog.com/2009/11/10/a-look-at-areva%e2%80%99s-work-for-the-advancement-of-nuclear-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>AREVA Med CEO Interview</title>
		<link>http://us.arevablog.com/2009/09/25/areva-med-ceo-interview/</link>
		<comments>http://us.arevablog.com/2009/09/25/areva-med-ceo-interview/#comments</comments>
		<pubDate>Fri, 25 Sep 2009 17:44:17 +0000</pubDate>
		<dc:creator>AREVA North America Blog</dc:creator>
				<category><![CDATA[Nuclear Energy]]></category>
		<category><![CDATA[Nuclear Medicine]]></category>

		<guid isPermaLink="false">http://us.arevablog.com/?p=1056</guid>
		<description><![CDATA[And if the AREVA Med recognition at the CGI event has you curious for more background on this effort, do see the interview with CEO Patrick Bourdet here:
http://djysrv.blogspot.com/2009/05/areva-enters-nuclear-medicine-market.html
]]></description>
		<wfw:commentRss>http://us.arevablog.com/2009/09/25/areva-med-ceo-interview/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Photos from AREVA at the Clinton Global Initiative Yesterday</title>
		<link>http://us.arevablog.com/2009/09/25/photos-from-areva-at-the-clinton-global-initiative-yesterday/</link>
		<comments>http://us.arevablog.com/2009/09/25/photos-from-areva-at-the-clinton-global-initiative-yesterday/#comments</comments>
		<pubDate>Fri, 25 Sep 2009 14:27:37 +0000</pubDate>
		<dc:creator>AREVA North America Blog</dc:creator>
				<category><![CDATA[Nuclear Energy]]></category>
		<category><![CDATA[Nuclear Medicine]]></category>
		<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://us.arevablog.com/?p=1043</guid>
		<description><![CDATA[N.Y. Times columnist Nicholas Kristof presents the CGI recognition to AREVA Med President Patrick Bourdet&#8230;




]]></description>
		<wfw:commentRss>http://us.arevablog.com/2009/09/25/photos-from-areva-at-the-clinton-global-initiative-yesterday/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Clinton Global Initiative Recognizes AREVA Med’s Efforts to Develop New Cancer Treatments</title>
		<link>http://us.arevablog.com/2009/09/24/clinton-global-initiative-recognizes-areva-med%e2%80%99s-efforts-to-develop-new-cancer-treatments/</link>
		<comments>http://us.arevablog.com/2009/09/24/clinton-global-initiative-recognizes-areva-med%e2%80%99s-efforts-to-develop-new-cancer-treatments/#comments</comments>
		<pubDate>Thu, 24 Sep 2009 18:11:03 +0000</pubDate>
		<dc:creator>AREVA North America Blog</dc:creator>
				<category><![CDATA[Nuclear Energy]]></category>
		<category><![CDATA[Nuclear Medicine]]></category>

		<guid isPermaLink="false">http://us.arevablog.com/?p=1036</guid>
		<description><![CDATA[Today in New York, the Clinton Global Initiative (CGI) recognized AREVA and its subsidiary AREVA Med LLC for its pioneering work in developing new methods for producing medical-grade Lead 212─ a promising isotope for combating cancer.
As the world leader in clean energy generation, AREVA has rather unique expertise in radiochemistry and nuclear engineering that now [...]]]></description>
		<wfw:commentRss>http://us.arevablog.com/2009/09/24/clinton-global-initiative-recognizes-areva-med%e2%80%99s-efforts-to-develop-new-cancer-treatments/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
	</channel>
</rss>
